AI Bias Analysis
4 models · Takes ~15 seconds
Metastatic pancreatic cancer patients who received a targeted pill from Revolution Medicines lived nearly twice as long as patients who got chemotherapy
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- Note that some links may require registration or subscription. Nutritionists are warning of increased cardiovascular and cancer risks amid surveys showing that Americans are upping their red meat intake. (NBC News) A second...
Revolution Medicines 'unprecedented' cancer trial data, Allogene's off-the-shelf CAR-T, and other biotech news
Landmines ahead for Vinay Prasad’s successor, hospitals and chatbots, and more health news from Morning Rounds
In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.
